Pharmacovigilance in developing countries (part I): importance and challenges |
| |
Authors: | Shaimaa Elshafie Iman Zaghloul Anne Marie Roberti |
| |
Institution: | 1.National Organization for Drug Control and Research,Cairo,Egypt;2.Massachusetts College of Pharmacy and Health Sciences University,Boston,USA;3.Independent Scholar,Wellesley,USA |
| |
Abstract: | The thalidomide disaster was the significant historical event that acted as a catalyst for pharmacovigilance activity. Following this event developed countries initiated drug monitoring systems that evolved and now extend their scope to broader drug-related safety issues; however, this was not the case in developing countries. Pharmacovigilance is still a relatively new concept with low priority in developing countries although various issues are raising concerns that magnify the need for systems to monitor post marketing drug safety in these countries. This article analyzes the barriers to introducing robust pharmacovigilance systems in developing countries. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|